{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T18:04:36Z","timestamp":1779559476167,"version":"3.53.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016545","name":"Roche Diagnostics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jcv.2026.105947","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:09:59Z","timestamp":1777306199000},"page":"105947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of a modified 2-step diagnostic algorithm for human immunodeficiency virus type 1 utilizing an HIV-1\/2 antigen\/antibody immunoassay screen and an HIV nucleic acid amplification test"],"prefix":"10.1016","volume":"184","author":[{"given":"Tessa M.","family":"Shates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Realegeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Starolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Marlowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2026.105947_bib1","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2026.105947_bib2","first-page":"2333","article-title":"Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure","volume":"14","author":"Lindb\u00e4ck","year":"2000","journal-title":"Karolinska Inst. Prim. HIV Infect. Study Group. AIDS"},{"key":"10.1016\/j.jcv.2026.105947_bib3","unstructured":"CDC. 2023. Technical Update for HIV Nucleic Acid Tests Approved for Diagnostic Purposes. \u3008https:\/\/WwwCdcGov\/Hiv\/Guidelines\/Recommendations\/Technical-Update-for-HivHtml\u3009."},{"key":"10.1016\/j.jcv.2026.105947_bib4","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/OLQ.0000000000001124","article-title":"Performance of an alternative laboratory-based HIV diagnostic testing algorithm using HIV-1 RNA viral load","volume":"47","author":"Pitasi","year":"2020","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jcv.2026.105947_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2014.10.010","article-title":"An HIV-1 RNA test following a reactive fourth-generation antigen\/antibody combination assay confirms a high proportion of HIV infections","author":"Westheimer","year":"2014","journal-title":"J. Clin. Virol. Publ. Pan Am. Soc. Clin. Virol. Neth."},{"key":"10.1016\/j.jcv.2026.105947_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.03030-20","article-title":"An HIV diagnostic testing algorithm using the cobas HIV-1\/HIV-2 qualitative assay for HIV type differentiation and confirmation","volume":"59","author":"Duncan","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2026.105947_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ajcp\/aqad002","article-title":"Implementation of an HIV RNA qualitative PCR assay in an HIV diagnostic algorithm: a single-institution experience","volume":"160","author":"Medeiros","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2026.105947_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/ciaf025","article-title":"Estimating the economic consequences of leveraging the Novel cobas HIV-1\/HIV-2 qualitative nucleic acid amplification test in routine HIV testing","volume":"81","author":"Bilir","year":"2025","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.jcv.2026.105947_bib9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1097\/QAD.0000000000001577","article-title":"The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion","volume":"31","author":"Donnell","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2026.105947_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jcv.2018.03.014","article-title":"Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag\/Ab Combo assay","volume":"Virol 104","author":"Lavoie","year":"2018","journal-title":"J. Clin. Virol. Publ. Pan Am. Soc. Clin."},{"key":"10.1016\/j.jcv.2026.105947_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/ciad264","article-title":"Increase in false-positive fourth-generation human immunodeficiency virus tests in patients with Coronavirus Disease 2019","volume":"77","author":"Gudipati","year":"2023","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.jcv.2026.105947_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/cid\/ciad608","article-title":"False-reactive fourth-generation human immunodeficiency virus testing in cancer patients","volume":"78","author":"Chiu","year":"2024","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.jcv.2026.105947_bib13","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2021.210308","article-title":"The optimal cutoff value to predict HIV infection using the architect HIV Ag\/Ab combo","volume":"68","author":"Zhang","year":"2022","journal-title":"Clin. Lab"},{"key":"10.1016\/j.jcv.2026.105947_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01204-22","article-title":"Utility of the signal-to-cutoff ratio and antigen index from fourth- and fifth-generation HIV-1\/HIV-2 antigen\/antibody assays for the diagnosis of acute HIV infection: applicability for real-time use for immediate initiation of antiretroviral therapy","volume":"60","author":"Whitney","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2026.105947_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22866","article-title":"Sample-to-cutoff ratios using Architect HIV Ag\/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection","volume":"33","author":"Wang","year":"2019","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.jcv.2026.105947_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120207","article-title":"Optimizing HIV testing: comparing diagnostic signatures and assay performance in ART-treated and general screening populations","volume":"570","author":"Liu","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jcv.2026.105947_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01273-25","article-title":"HIV serologic reactivity varies with time of ART initiation in persons on long-term ART","volume":"64","author":"Avelino-Silva","year":"2026","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2026.105947_bib18","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/OLQ.0000000000001137","article-title":"Could HIV-1 RNA testing be an option as the second step in the HIV diagnostic algorithm?","volume":"47","author":"Masciotra","year":"2020","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jcv.2026.105947_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cid\/ciw365","article-title":"Initiation of antiretroviral therapy during acute HIV-1 infection leads to a high rate of nonreactive HIV Serology","volume":"63","author":"de Souza","year":"2016","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.jcv.2026.105947_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00757-19","article-title":"Decreased seroreactivity in individuals initiating antiretroviral therapy during acute HIV infection","volume":"57","author":"Manak","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2026.105947_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/aid.2020.0137","article-title":"Altered antibody responses in persons infected with HIV-1 while using preexposure prophylaxis","volume":"37","author":"Parker","year":"2021","journal-title":"AIDS Res Hum. Retrovir."},{"key":"10.1016\/j.jcv.2026.105947_bib22","unstructured":"United States. Public Health Service;Centers for Disease Control and Prevention (U.S.);National Center for HIV\/AIDS, Viral Hepatitis, STD and TP (U. S). D of HPPPWG. 2021. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States \u2013 2021 Update: A Clinical Practice Guideline."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:15:06Z","timestamp":1779556506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653226000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":22,"alternative-id":["S1386653226000363"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2026.105947","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a modified 2-step diagnostic algorithm for human immunodeficiency virus type 1 utilizing an HIV-1\/2 antigen\/antibody immunoassay screen and an HIV nucleic acid amplification test","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2026.105947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105947"}}